[OH:1][CH:2]([CH:23]([CH3:25])[CH3:24])[C:3]#[C:4][C:5]1[CH:6]=[CH:7][C:8]2[N:9]([C:11]([CH2:14][NH:15][C:16](=[O:22])[O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[N:12][N:13]=2)[N:10]=1>C(Cl)Cl.[O-2].[O-2].[Mn+4]>[CH3:24][CH:23]([CH3:25])[C:2](=[O:1])[C:3]#[C:4][C:5]1[CH:6]=[CH:7][C:8]2[N:9]([C:11]([CH2:14][NH:15][C:16](=[O:22])[O:17][C:18]([CH3:20])([CH3:19])[CH3:21])=[N:12][N:13]=2)[N:10]=1tert-Butyl (6-(3-hydroxy-4-methylpent-1-ynyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate (1.82 g, 5.27 mmol) and manganese dioxide (activated) (9.16 g, 105 mmol) were dissolved in DCM (263 mL) and stirred at room temperature over two days. Additional manganese dioxide (activated) (4.58 g, 52.7 mmol) was added and stirring continued overnight. The reaction mixture was filtered over a plug of Celite and washed with DCM to yield tert-butyl (6-(4-methyl-3-oxopent-1-ynyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate (0.917 g, 50.7% yield) after concentration in vacuo.